Details of Disease

Disease Name

Disease Class

1C12: Whooping cough

Disease Hierarchy

DIS01GPL: Grass pollen hypersensitivity

DIS60FPT: Pertussis

ICD-11

ICD-11: 1C12

Disease Identifiers

MONDO ID

MONDO_0005077

MESH ID

D014917

UMLS CUI

C0043167

MedGen ID

12159

Orphanet ID

1489

SNOMED CT ID

27836007

General Information of Disease (ID: DIS60FPT)

Drug-Interaction Atlas (DIA) of This Disease

Drug-Interaction Atlas (DIA)

This Disease is Treated as An Indication in 1 Approved Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
Infanrix hexa	DM4DCZX	Approved in EU	Vaccine	[1]
------------------------------------------------------------------------------------

This Disease is Treated as An Indication in 3 Clinical Trial Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
Shan 6	DMGSX7D	Phase 3	NA	[2]
BPZE1	DM3RE3V	Phase 2	Vaccine	[3]
SP0173	DMAYY9O	Phase 1/2	Vaccine	[4]
------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)

References

1	EU Approved Drug Products from EU Official Website.
2	ClinicalTrials.gov (NCT04429295) Study of DTwP-HepB-Hib-IPV (SHAN6) Vaccine Administered Concomitantly With Routine Pediatric Vaccines to Healthy Infants and Toddlers in Thailand. U.S. National Institutes of Health.
3	ClinicalTrials.gov (NCT03541499) Safety and Immunogenicity of Intranasal BPZE1 Vaccination in Healthy Adults. U.S. National Institutes of Health.
4	ClinicalTrials.gov (NCT02587520) Study of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed in Healthy Subjects. U.S. National Institutes of Health.